The RANKL inhibitor denosumab in combination with dual checkpoint inhibition is associated with increased CXCL-13 serum concentrations
Titel:
The RANKL inhibitor denosumab in combination with dual checkpoint inhibition is associated with increased CXCL-13 serum concentrations
Auteur:
Schaper-Gerhardt, Katrin Gutzmer, Ralf Angela, Yenny Zimmer, Lisa Livingstone, Elisabeth Schadendorf, Dirk Hassel, Jessica C. Weishaupt, Carsten Remes, Bernhard Kubat, Linda Spassova, Ivelina Becker, Jürgen C.